213 related articles for article (PubMed ID: 21991614)
21. Drug secondary prevention in postmenopausal women with ischemic heart disease.
Zdrenghea D; Pop D; Sitar-Tăut A; Cebanu M; Zdrenghea V
Rom J Intern Med; 2009; 47(1):41-5. PubMed ID: 19886068
[TBL] [Abstract][Full Text] [Related]
22. Comparative effects of cilazapril, carvedilol and their combination in preventing from left ventricular remodelling after acute myocardial infarction in rats.
Yang Y; Tang Y; Ruan Y; Li Y; Zhou Y; Gao R; Chen J; Chen Z
J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):31-5. PubMed ID: 11984745
[TBL] [Abstract][Full Text] [Related]
23. Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis.
Choudhry NK; Avorn J; Antman EM; Schneeweiss S; Shrank WH
Health Aff (Millwood); 2007; 26(1):186-94. PubMed ID: 17211028
[TBL] [Abstract][Full Text] [Related]
24. Carvedilol: use in chronic heart failure.
Doughty RN; White HD
Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
[TBL] [Abstract][Full Text] [Related]
25. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
Hudson M; Richard H; Pilote L
Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):773-85. PubMed ID: 17486661
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular risk in patients with type 2 diabetes.
Shanks M; Holmes DT; Cermakova L; Frohlich J
CMAJ; 2005 Apr; 172(9):1160-1. PubMed ID: 15851694
[No Abstract] [Full Text] [Related]
27. [Drug treatment following an infarction].
Lasserre B; Périat M
Rev Med Suisse Romande; 1994 Aug; 114(8):677-81. PubMed ID: 7939090
[No Abstract] [Full Text] [Related]
28. Secondary prevention for patients following a myocardial infarction: summary of NICE guidance.
Skinner JS; Cooper A; Feder GS;
Heart; 2007 Jul; 93(7):862-4. PubMed ID: 17569811
[TBL] [Abstract][Full Text] [Related]
29. [Quality of treatment after myocardial infarction: impact of hospital guidelines].
von Gunten V; Sierro C; Rosiak S; Weibel ML; Petignat PA; Girod G; Beney J
Rev Med Suisse; 2013 Nov; 9(406):2107-11. PubMed ID: 24383285
[TBL] [Abstract][Full Text] [Related]
30. Do All Patients Need β-Blockers After a Heart Attack?
Abbasi J
JAMA; 2018 Mar; 319(9):853-855. PubMed ID: 29450492
[No Abstract] [Full Text] [Related]
31. [Pharmacotherapy following myocardial infarction].
Spinarová L; Spinar J; Vítovec J
Vnitr Lek; 2011 Nov; 57(11):966-9. PubMed ID: 22165705
[TBL] [Abstract][Full Text] [Related]
32. [ASA therapy or not?].
Strandberg T; Vanhanen H
Duodecim; 2002; 118(6):557-9. PubMed ID: 12232998
[No Abstract] [Full Text] [Related]
33. Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables.
Feher G; Koltai K; Papp E; Alkonyi B; Solyom A; Kenyeres P; Kesmarky G; Czopf L; Toth K
Drugs Aging; 2006; 23(7):559-67. PubMed ID: 16930084
[TBL] [Abstract][Full Text] [Related]
34. Ask the doctor. My doctor and I are confused by my cholesterol levels. My good cholesterol is extraordinarily high, at 94, but my bad cholesterol is on the high side, too, at 154. To resolve this good news/bad news story, my doctor ordered a C-reactive protein test which, of course, came back right in the middle of the normal range. I don't smoke or have other factors for heart disease. Would you advise me at start a statin or some other drug?
Lee T
Harv Heart Lett; 2006 Apr; 16(8):8. PubMed ID: 19681197
[No Abstract] [Full Text] [Related]
35. Non ST-elevation myocardial infarction: New Zealand management guidelines.
;
N Z Med J; 2005 Oct; 118(1223):U1680. PubMed ID: 16224504
[No Abstract] [Full Text] [Related]
36. Do the current medical and economic times dictate the need for the "polypill"?
Rifai L; Khan BV
J Clin Hypertens (Greenwich); 2009 Dec; 11(12):775-6. PubMed ID: 20021541
[No Abstract] [Full Text] [Related]
37. Effect of age on the use of evidence-based therapies for acute myocardial infarction.
Tran CT; Laupacis A; Mamdani MM; Tu JV
Am Heart J; 2004 Nov; 148(5):834-41. PubMed ID: 15523314
[TBL] [Abstract][Full Text] [Related]
38. Renal and cardiac function during alpha1-beta-blockade in congestive heart failure.
Heitmann M; Davidsen U; Stokholm KH; Rasmussen K; Burchardt H; Petersen EB
Scand J Clin Lab Invest; 2002; 62(2):97-104. PubMed ID: 12004934
[TBL] [Abstract][Full Text] [Related]
39. Recent developments in secondary prevention and cardiac rehabilitation after acute myocardial infarction.
Dalal H; Evans PH; Campbell JL
BMJ; 2004 Mar; 328(7441):693-7. PubMed ID: 15031243
[TBL] [Abstract][Full Text] [Related]
40. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
